-20webclip.png)
£25.5M
The financing will be used to expand technical teams and accelerate the commercialisation of its proteomics platform.
PB
Portal Biotech
Portal Biotech delivers single-molecule protein sequencing technology to transform proteomics and drug discovery.
London, UK—Founded 2021
£25.5MTotal raised
Portal Biotech develops a proteomics platform technology that enables full-length protein sequencing and characterisation. The company aims to transform drug development, precision medicine, and diagnostics.
Categories
Founders
Andy Heron
Co-founder and CEO
Andy is the co-founder and chief executive officer of Portal Biotech. He previously spent a decade at Oxford Nanopore Technologies, culminating in his role as senior director of advanced research.
LinkedIn